![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Pfizer to Buy AstraZeneca Antibiotics for Up to $1.5 Billion
Pfizer to Buy AstraZeneca Antibiotics for Up to $1.5 Billion
Pfizer struck an agreement with AstraZeneca to acquire the company’s late-stage small molecule anti-infectives business, which operates primarily outside of the United States, for up to $1.5 billion.
The deal includes upfront, milestone and sales-related payments of up to $1.34 billion as well as an additional close-of-transaction deferred payment of $175 million in January 2019.
The acquired portfolio comprises the drugs Zavicefta, Merrem, and Zinforo and two candidates in clinical development, ATM-AVI and CXL.
The parties expect the deal to close in the fourth quarter.
Upcoming Events
-
21Oct